Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9077 |
High Similarity |
NPD230 |
Phase 1 |
0.8661 |
High Similarity |
NPD9269 |
Phase 2 |
0.856 |
High Similarity |
NPD9545 |
Approved |
0.8489 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8346 |
Intermediate Similarity |
NPD9268 |
Approved |
0.8296 |
Intermediate Similarity |
NPD943 |
Approved |
0.8284 |
Intermediate Similarity |
NPD3764 |
Approved |
0.8239 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8195 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8125 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8121 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8115 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7902 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7867 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7862 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD447 |
Suspended |
0.782 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7801 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7763 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7761 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7639 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7616 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7594 |
Intermediate Similarity |
NPD17 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7557 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7556 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7518 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7481 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7467 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7383 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7376 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7357 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7287 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7287 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7286 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7284 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7266 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7258 |
Intermediate Similarity |
NPD1238 |
Approved |
0.7254 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7239 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD258 |
Approved |
0.7214 |
Intermediate Similarity |
NPD257 |
Approved |
0.7211 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7209 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7209 |
Intermediate Similarity |
NPD74 |
Approved |
0.7195 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7194 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7192 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7176 |
Intermediate Similarity |
NPD228 |
Approved |
0.7164 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD9569 |
Approved |
0.716 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD826 |
Approved |
0.7153 |
Intermediate Similarity |
NPD825 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7133 |
Intermediate Similarity |
NPD411 |
Approved |
0.7132 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7132 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7132 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7105 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7105 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7103 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD555 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD259 |
Phase 1 |
0.7078 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7075 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7067 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.705 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7032 |
Intermediate Similarity |
NPD824 |
Approved |
0.7027 |
Intermediate Similarity |
NPD9570 |
Approved |
0.702 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD919 |
Approved |
0.6993 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6992 |
Remote Similarity |
NPD1202 |
Approved |
0.698 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD2353 |
Approved |
0.6978 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6978 |
Remote Similarity |
NPD1281 |
Approved |
0.6974 |
Remote Similarity |
NPD7440 |
Discontinued |
0.697 |
Remote Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD1778 |
Approved |
0.6957 |
Remote Similarity |
NPD5494 |
Approved |
0.6946 |
Remote Similarity |
NPD7039 |
Approved |
0.6946 |
Remote Similarity |
NPD7038 |
Approved |
0.6944 |
Remote Similarity |
NPD9537 |
Phase 1 |
0.6944 |
Remote Similarity |
NPD9536 |
Phase 1 |
0.6944 |
Remote Similarity |
NPD7095 |
Approved |
0.694 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6929 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6923 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6918 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.6913 |
Remote Similarity |
NPD2796 |
Approved |
0.6903 |
Remote Similarity |
NPD920 |
Approved |
0.6903 |
Remote Similarity |
NPD5403 |
Approved |
0.6901 |
Remote Similarity |
NPD2797 |
Approved |
0.6899 |
Remote Similarity |
NPD164 |
Approved |
0.6899 |
Remote Similarity |
NPD37 |
Approved |
0.6897 |
Remote Similarity |
NPD3268 |
Approved |
0.6897 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6889 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD9281 |
Approved |
0.6887 |
Remote Similarity |
NPD1243 |
Approved |
0.6885 |
Remote Similarity |
NPD9256 |
Approved |
0.6885 |
Remote Similarity |
NPD9258 |
Approved |
0.6883 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD5401 |
Approved |
0.6883 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD4966 |
Approved |
0.6875 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD4965 |
Approved |
0.6871 |
Remote Similarity |
NPD275 |
Approved |
0.6871 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6871 |
Remote Similarity |
NPD274 |
Approved |
0.687 |
Remote Similarity |
NPD1358 |
Approved |
0.6867 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD1006 |
Clinical (unspecified phase) |
0.6853 |
Remote Similarity |
NPD2798 |
Approved |
0.6849 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD7003 |
Approved |
0.6842 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6842 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6839 |
Remote Similarity |
NPD9509 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD6273 |
Approved |
0.6831 |
Remote Similarity |
NPD1876 |
Approved |
0.6822 |
Remote Similarity |
NPD9261 |
Approved |
0.6818 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6818 |
Remote Similarity |
NPD2182 |
Approved |
0.681 |
Remote Similarity |
NPD2821 |
Approved |
0.681 |
Remote Similarity |
NPD1247 |
Approved |
0.681
|
Remote Similarity |
NPD7199 |
Phase 2 |